Clinical Trials · NCT00170157
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Mayo Clinic
- Enrollment
- 112
- Start date
- Jun 2004
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants Progression-free at 18 Months